The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Outreach and support in South London (OASIS), 2001–2011: Ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis
Open accessAbstract
Introduction: Prevention of psychosis has become a major objective of modern clinical psychiatry. An increasing number of new services have been established in Europe and in the world. The OASIS team has become an established model where clinical practice and research are fully integrated in the field of preventative interventions in psychosis. Method: Comprehensive analysis of different clinical and service measures describing the 2001–2011 implementation of the OASIS team. Results: Over the last decade, the OASIS team has received a total of 1102 referrals, mostly young males from ethnic minorities. After the assessment, 35% were diagnosed with an At Risk Mental State (ARMS) while 32% were already psychotic. Within the ARMS, 70% met the inclusion criteria for the attenuated psychotic symptoms subgroup, 1% met the inclusion criteria for the genetic deterioration syndrome, 9% met inclusion criteria for a brief and self-limited intermittent psychotic episode and the others met inclusion criteria for more than one subgroup. Most of them had at least one comorbid diagnosis, mainly relating to anxiety and depressive domains. The majority of the OASIS clients received cognitive behavioural therapy alone or in combination with antidepressants/antipsychotics. Over the 2-year follow-up time, 44 subjects (15.2%) developed a frank psychotic episode. Conclusions: The OASIS service represents one of the largest and most established prodromal services in the world. The burden of research evidence and the translational impact produced on the clinical practice support the OASIS as a model for the development of similar services.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review
Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.269 · Cited by 1,483 · cited 1×
“[17]).”
Self-citationPsychosis prediction: 12-month follow up of a high-risk ("prodromal") group
Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., Hallgren, M., & McGorry, P. D. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00167-6 · Cited by 1,136
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Self-citationCognitive Functioning in Prodromal Psychosis: A Meta-analysis
Fusar-Poli, P., Deste, G., Smieskova, R., Barlati, S., Yung, A. R., Howes, O., Stieglitz, R.-D., Vita, A., McGuire, P., & Borgwardt, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1592 · Cited by 691 · cited 1×
“Broadly speaking the high risk state is characterized by the presence of subtresholded psychotic symptoms, cognitive and neurobiological deficits [28,37,31,16] and significant limitations in psychosocial functioning [1].”
BackgroundSelf-citationFusar-Poli, P., Nelson, B., Valmaggia, L., Yung, A. R., & McGuire, P. K. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs136 · Cited by 589 · cited 1×
“Most of the ARMS had at least one comorbid diagnosis, mainly relating to anxiety and depressive domains, in line with recent evidence in high risk samples [22].”
ResultSelf-citationHigh-potency cannabis and the risk of psychosis
Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.064220 · Cited by 567
Yung, A. R., Nelson, B., Stanford, C., Simmons, M. B., Cosgrave, E. M., Killackey, E., Phillips, L. J., Bechdolf, A., Buckby, J., & McGorry, P. D. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.012 · Cited by 358
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010160 · Cited by 343
Self-citationSocial functioning in individuals at clinical high risk for psychosis
Addington, J., Penn, D., Woods, S. W., Addington, D., & Perkins, D. O. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.001 · Cited by 265 · cited 2×
“Broadly speaking the high risk state is characterized by the presence of subtresholded psychotic symptoms, cognitive and neurobiological deficits [28,37,31,16] and significant limitations in psychosocial functioning [1].”
Background
Cited by
Age at onset of mental disorders worldwide: Large-scale meta-analysis of 192 epidemiological studies
Solmi, M., Radua, J., Olivola, M., Croce, E., Soardo, L., Salazar de Pablo, G., Il Shin, J., Kirkbride, J. B., Jones, P., Kim, J. H., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01161-7 · Cited by 3,835
Self-citationBarnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Fusar-Poli, P., Nelson, B., Valmaggia, L., Yung, A. R., & McGuire, P. K. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs136 · Cited by 589
Self-citationEPA guidance on the early intervention in clinical high risk states of psychoses
Schmidt, S. J., Schultze-Lutter, F., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., Riecher-Rössler, A., van der Gaag, M., Meneghelli, A., Nordentoft, M., Marshall, M., et al. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.01.013 · Cited by 585
“1%) each from the Netherlands [116,120,135] and the UK [26,69–72], two (4.”
BackgroundImproving outcomes of first‐episode psychosis: an overview
Fusar‐Poli, P., McGorry, P. D., & Kane, J. M. (2017) · World Psychiatry · doi:10.1002/wps.20446 · Cited by 575
Self-citationAltering the course of schizophrenia: progress and perspectives
Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516
Self-citationPreventive psychiatry: a blueprint for improving the mental health of young people
Fusar‐Poli, P., Correll, C. U., Arango, C., Berk, M., Patel, V., & Ioannidis, J. P. A. (2021) · World Psychiatry · doi:10.1002/wps.20869 · Cited by 497
Self-citationBloomfield, P. S., Selvaraj, S., Veronese, M., Rizzo, G., Bertoldo, A., Owen, D. R., Bloomfield, M. A. P., Bonoldi, I., Kalk, N., Turkheimer, F., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14101358 · Cited by 443
Self-citationEPA guidance on the early detection of clinical high risk states of psychoses
Schultze-Lutter, F., Michel, C., Schmidt, S. J., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., Riecher-Rössler, A., van der Gaag, M., Nordentoft, M., Raballo, A., et al. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.01.010 · Cited by 405
What is good mental health? A scoping review
Fusar-Poli, P., Salazar de Pablo, G., De Micheli, A., Nieman, D. H., Correll, C. U., Kessing, L. V., Pfennig, A., Bechdolf, A., Borgwardt, S., Arango, C., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.12.105 · Cited by 356
Self-citationReininghaus, U., Kempton, M. J., Valmaggia, L., Craig, T. K. J., Garety, P., Onyejiaka, A., Gayer-Anderson, C., So, S. H., Hubbard, K., Beards, S., et al. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv190 · Cited by 304
Self-citationFusar-Poli, P., Rutigliano, G., Stahl, D., Davies, C., Bonoldi, I., Reilly, T., & McGuire, P. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0284 · Cited by 246
Self-citationFusar‐Poli, P., Cappucciati, M., Rutigliano, G., Schultze‐Lutter, F., Bonoldi, I., Borgwardt, S., Riecher‐Rössler, A., Addington, J., Perkins, D., Woods, S. W., et al. (2015) · World Psychiatry · doi:10.1002/wps.20250 · Cited by 234
Self-citationFusar-Poli, P., Schultze-Lutter, F., Cappucciati, M., Rutigliano, G., Bonoldi, I., Stahl, D., Borgwardt, S., Riecher-Rössler, A., Addington, J., Perkins, D. O., et al. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv162 · Cited by 219
Self-citationFusar-Poli, P. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00355 · Cited by 218
Self-citationRonald, A., Sieradzka, D., Cardno, A. G., Haworth, C. M. A., McGuire, P., & Freeman, D. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt106 · Cited by 211
Self-citationCognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis
Hutton, P., & Taylor, P. J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000354 · Cited by 184
“However the control group transition rate of 9% (4% in CBT; 6% overall) was lower than other meta-analytical estimates, where 18% were found to make transition over 6 months (Fusar-Poli et al., 2012a).”
BackgroundMethodResultInfluentialPrognosis of Brief Psychotic Episodes: A Meta-analysis
Fusar-Poli, P., Cappucciati, M., Bonoldi, I., Hui, L. M. C., Rutigliano, G., Stahl, D. R., Borgwardt, S., Politi, P., Mishara, A. L., Lawrie, S. M., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2313 · Cited by 151
Self-citationRutigliano, G., Valmaggia, L., Landi, P., Frascarelli, M., Cappucciati, M., Sear, V., Rocchetti, M., De Micheli, A., Jones, C., Palombini, E., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.053 · Cited by 138
“All the subjects assessed at the OASIS clinic (Fusar-Poli et al., 2013b) in the period 2001-2012 and deemed to endorse a UHR state were considered eligible for this study.”
BackgroundMethodSelf-citationFusar-Poli, P., Rutigliano, G., Stahl, D., Davies, C., De Micheli, A., Ramella-Cravaro, V., Bonoldi, I., & McGuire, P. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2016.11.010 · Cited by 120
Self-citationValmaggia, L. R., Stahl, D., Yung, A. R., Nelson, B., Fusar-Poli, P., McGorry, P. D., & McGuire, P. K. (2013) · Psychological Medicine · doi:10.1017/s0033291713000251 · Cited by 121
Self-citationFusar-Poli, P., Rutigliano, G., Stahl, D., Schmidt, A., Ramella-Cravaro, V., Hitesh, S., & McGuire, P. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2707 · Cited by 121
Self-citationPreventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
Fusar-Poli, P., Davies, C., Solmi, M., Brondino, N., De Micheli, A., Kotlicka-Antczak, M., Shin, J. I., & Radua, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00764 · Cited by 108
Self-citationFusar-Poli, P., Werbeloff, N., Rutigliano, G., Oliver, D., Davies, C., Stahl, D., McGuire, P., & Osborn, D. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby070 · Cited by 95
Self-citationFusar-Poli, P., Sullivan, S. A., Shah, J. L., & Uhlhaas, P. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00774 · Cited by 92
Self-citationIrving, J., Patel, R., Oliver, D., Colling, C., Pritchard, M., Broadbent, M., Baldwin, H., Stahl, D., Stewart, R., & Fusar-Poli, P. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa126 · Cited by 92
Self-citation‘At risk mental state’ clinics for psychosis – an idea whose time has come – and gone!
Ajnakina, O., David, A. S., & Murray, R. M. (2019) · Psychological Medicine · doi:10.1017/s0033291718003859 · Cited by 82
“The definition of this pre-psychosis phase in which people manifested the At Risk Mental State (ARMS) (Fusar-Poli et al., 2013) was followed by claims that identification of such individuals who were at ultrahigh risk (UHR) of developing psychosis, provides a valuable opportunity to prevent a substantial proportion of…”
InfluentialBossong, M. G., Antoniades, M., Azis, M., Samson, C., Quinn, B., Bonoldi, I., Modinos, G., Perez, J., Howes, O. D., Stone, J. M., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3252 · Cited by 81
Self-citationFusar-Poli, P., Frascarelli, M., Valmaggia, L., Byrne, M., Stahl, D., Rocchetti, M., Codjoe, L., Weinberg, L., Tognin, S., Xenaki, L., et al. (2015) · Psychological Medicine · doi:10.1017/s003329171400244x · Cited by 73
Self-citationAppiah-Kusi, E., Fisher, H. L., Petros, N., Wilson, R., Mondelli, V., Garety, P. A., Mcguire, P., & Bhattacharyya, S. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.01.003 · Cited by 71
Self-citationBlunted cortisol awakening response in people at ultra high risk of developing psychosis
Day, F. L., Valmaggia, L. R., Mondelli, V., Papadopoulos, A., Papadopoulos, I., Pariante, C. M., & McGuire, P. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.041 · Cited by 66
Bowtell, M., Ratheesh, A., McGorry, P., Killackey, E., & O'Donoghue, B. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.11.010 · Cited by 62
Fusar-Poli, P., Spencer, T., De Micheli, A., Curzi, V., Nandha, S., & McGuire, P. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.08.002 · Cited by 57
Self-citationTognin, S., Pettersson-Yeo, W., Valli, I., Hutton, C., Woolley, J., Allen, P., McGuire, P., & Mechelli, A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00187 · Cited by 56
Self-citationWinton-Brown, T., Schmidt, A., Roiser, J. P., Howes, O. D., Egerton, A., Fusar-Poli, P., Bunzeck, N., Grace, A. A., Duzel, E., Kapur, S., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.174 · Cited by 51
Self-citationOliver, D., Spada, G., Colling, C., Broadbent, M., Baldwin, H., Patel, R., Stewart, R., Stahl, D., Dobson, R., McGuire, P., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.007 · Cited by 49
“Moreover, psychosis can also originate outside the CHR-P (Lee et al., 2018), frequently from underlying affective disorders (Mishara and Fusar-Poli, 2013).”
Self-citationPsychosis Risk and Development: What Do We Know From Population-Based Studies?
Mennigen, E., & Bearden, C. E. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.12.014 · Cited by 40
Schmidt, A., Antoniades, M., Allen, P., Egerton, A., Chaddock, C. A., Borgwardt, S., Fusar-Poli, P., Roiser, J. P., Howes, O., & McGuire, P. (2017) · Psychological Medicine · doi:10.1017/s0033291716002439 · Cited by 38
Neural circuitry of novelty salience processing in psychosis risk: Association with clinical outcome
Modinos, G., Allen, P., Zugman, A., Dima, D., Azis, M., Samson, C., Bonoldi, I., Quinn, B., Gifford, G. W. G., Smart, S. E., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz089 · Cited by 31
Self-citationReal-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study
Oliver, D., Spada, G., Englund, A., Chesney, E., Radua, J., Reichenberg, A., Uher, R., McGuire, P., & Fusar-Poli, P. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.04.015 · Cited by 27
Self-citationFusar-Poli, P., De Micheli, A., Patel, R., Signorini, L., Miah, S., Spencer, T., & McGuire, P. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa040 · Cited by 22
Self-citationThe CEDAR study group, Loos, S., Arnold, K., Slade, M., Jordan, H., Vecchio, V. D., Sampogna, G., Süveges, Á., Nagy, M., Krogsgaard Bording, M., et al. (2015) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0963-4 · Cited by 8
Wilson, R. P., Patel, R., & Bhattacharyya, S. (2017) · Early Intervention in Psychiatry · doi:10.1111/eip.12311 · Cited by 6
Fusar-Poli, P., Oliver, D., Spada, G., Estrade, A., & McGuire, P. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.11.031 · Cited by 6
Metadata
- Authors
- Fusar-Poli, P., Byrne, M., Badger, S., Valmaggia, L. R., & McGuire, P. K.
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2013-06
- Volume
- 28
- Issue
- 5
- Pages
- 315-326
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2140741029
- Cited by
- 197
- References
- 16
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.